Home›China›郑州标源生物科技有限公司

郑州标源生物科技有限公司

China

✓ Record-verifiedregistrations found in 1 markets

This company holds 32 NMPA certificates in China.

Registrations by market

Each market counts a different unit; figures are not directly comparable

CNChinaNMPA

32China registrations

Class I 1Class II 24Class III 7

as of 2026-09-04

EUEuropean UnionEUDAMED

pendingnot queried

USUnited StatesFDA openFDA

pendingnot queried

UKUnited KingdomMHRA PARD

pendingnot queried

BRBrazilANVISA

pendingnot queried

this export covers Class I / II only (the cadastro route)

SASaudi ArabiaSFDA

pendingnot queried

low-risk imported devices only; a 2023 snapshot, not updated since

CACanadaMDALL

pendingnot queried

TWTaiwanTFDA

pendingnot queried

SGSingaporeHSA SMDR

pendingnot queried

KRSouth KoreaMFDS GMP

pendingnot queried

AUAustraliaTGA ARTG

pendingnot queried

HKHong KongMDACS

pendingnot queried

ILIsraelAMAR

pendingnot queried

RURussiaRoszdravnadzor

pendingnot queried

Not yet connected: India CDSCO, Indonesia Kemenkes. The public search for Japan PMDA and Vietnam IMDA does not return manufacturer names, so entries cannot be linked to companies coming — where there is no data it is shown as "pending", never estimated.

How these numbers were verified

record-verified

Company-name search in every official database is a substring match and returns same-named but different companies. Each figure below is the count after re-checking every record against the manufacturer name.

China32 certificates (Class III 7 / II 24 / I 1), as of 2026-09-04

Registration details (sample)

Market	Identifier	Name	Class / date
CN	国械注准20253401570	异常凝血酶原/人表皮生长因子受体2/胃泌素释放肽前体/胃泌素17/S100蛋白质控品	Class III
CN	国械注准20253401155	EB病毒抗体质控品Ⅰ	Class III
CN	国械注准20233400212	肿瘤标志物质控品	Class III
CN	国械注准20213401014	乙肝表面抗原/乙肝e抗原/丙肝抗体/人类免疫缺陷病毒抗体/梅毒螺旋体抗体质控品	Class III

郑州标源生物科技有限公司

Registrations by market

How these numbers were verified

Company information

Registration details (sample)

Similar companies